The Environmental Determinants of Diabetes in the Young (TEDDY): Genetic criteria and international diabetes risk screening of 421 000 infants

Pediatric Diabetes

Volumn 12, Issue 8, 2011, Pages 733-743

  Hagopian, William A ^a   Erlich, Henry ^b   Lernmark, Åke ^c   Rewers, Marian ^d   Ziegler, Anette G ^e   Simell, Olli ^f   Akolkar, Beena ^g   Vogt, Robert ^h   Blair, Alan ^b   Ilonen, Jorma ^f,i   Krischer, Jeffrey ^j   She, Jinxiong ^k  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF COLORADO DENVER   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF TURKU   (Finland)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ UNIVERSITY OF EASTERN FINLAND   (Finland)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k MEDICAL COLLEGE OF GEORGIA   (United States)

more..

Author keywords

Autoimmunity; Genetic screening; Population based; Prediction; T1D

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ENVIRONMENTAL FACTOR; FOLLOW UP; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HIGH RISK POPULATION; HLA TYPING; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; POPULATION; PRIORITY JOURNAL;

COHORT STUDIES; DIABETES MELLITUS, TYPE 1; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; QUALITY CONTROL; RISK;

EID: 80053036722     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00774.x     Document Type: Article

References (28)

1. She JX. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996: 17: 323-329.
2. Smyth DJ, Cooper JD, Bailey R et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006: 38: 617-619.
3. WTCCC. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007: 447: 661-678.
4. Barrett JC, Clayton DG, Concannon P et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009: 41: 703-707.
5. Hakonarson H, Grant SFA, Bradfield JP et al. A genome-wide association study identifies KIAA0 350 as a type 1 diabetes gene. Nature 2007: 448: 591-594.
6. Knip M, Veijola R, Virtanen SM et al. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005: 54: S125-S136.
7. Peng H, Hagopian W. Environmental factors in the development of type 1 diabetes. Rev Endocr Metab Disord 2006: 7: 149-162.
8. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr Diabetes 2007: 8: 286-298.
9. She JX, Bui MM, Tian XH et al. Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity 1994: 18: 195-203.
10. Bonifacio E, Hummel M, Walter M et al. IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care 2005: 27: 2695-2700.
11. Emery LM, Babu S, Bugawan TL et al. Newborn HLA-DR, DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates. Pediatr Diabetes 2005: 6: 136-144.
12. Kockum I, Sanjeevi CB, Eastman S et al. Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur J Immunogenet 1999: 26: 361-372.
13. Hermann R, Turpeinen H, Laine AP et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003: 62: 162-169.
14. Wion E, Brantley M, Stevens J et al. Population-wide infant screening for HLA-based type 1 diabetes risk via dried bloodspots from the public health infrastructure. Annals NY Acad Sci 2003: 1005: 400-404.
15. Kiviniemi M, Hermann R, Nurmi J et al. A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther 2007: 9: 460-472.
16. Erlich H, Valdes AM, Noble J et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008: 57: 1084-1092.
17. Liese AD, D'Agostino RB Jr, Hamman RF et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006: 118: 1510-1518.
18. Agrawal S, Khan F, Bharadwaj U. Human genetic variation studies and HLA class II loci. Int J Immunogenet 2007: 34: 247-252.
19. Thomson G, Valdes AM, Noble JA et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007: 70: 110-127.
20. Carmichael SK, Johnson SB, Baughcum A et al. Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk. Genet Med 2003: 5: 77-83.
21. Nejentsev S, Sjoroos M, Soukka T et al. Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 1999: 16: 985-992.
22. Kupila A, Muona P, Simell T et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001: 44: 290-297.
23. Ilonen J, Sjoroos M, Knip M et al. Estimation of genetic risk for type 1 diabetes. Am J Med Genet 2002: 115: 30-36.
24. Ilonen J, Reijonen H, Knip M et al. Population-based genetic screening for IDDM susceptibility as a source of HLA-genotyped control subjects. Diabetologia 1996: 39: 123.
25. Rewers M, Bugawan TL, Norris JM et al. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 1996: 39: 807-812.
26. Akerblom HK, Knip M, Becker D et al. The TRIGR trial: testing the potential link between weaning diet and type 1 diabetes. Immunol Endocr Metab Agents Med Chem 2007: 7: 251-263.
27. Van der Auwera BJ, Schuit FC, Weets I et al. Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population: implications for future prevention studies. Hum Immunol 2002: 63: 40-50.
28. Van der Auwera B, Van Waeyenberge C, Schuit F et al. DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Diabetes 1995: 44: 527-530.